Related Experiment Video

Updated: May 28, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B

Megan H Powdrill1, Jean A Bernatchez2, Matthias Götte1,2

  • 1McGill University, Department of Microbiology and Immunology, 3775 University Room D6, Montreal Quebec, H3A2B4, Canada.

Viruses
|October 14, 2011
PubMed

Insights

Current hepatitis C virus (HCV) treatments are limited. New direct-acting antivirals (DAAs) targeting the HCV RNA polymerase (NS5B) show promise, but antiviral resistance is a key challenge.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection remains a significant global health concern.
  • Current standard therapy (pegylated interferon-α and ribavirin) has limitations including severe side effects and suboptimal efficacy.
  • The development of specifically targeted antiviral therapies for HCV (STAT-C) represents a paradigm shift in treatment.

Purpose of the Study:

  • To review the current development status of direct-acting antivirals (DAAs) targeting the HCV RNA-dependent RNA polymerase (NS5B).
  • To discuss the critical issue of antiviral resistance emerging during NS5B inhibitor therapy.
  • To explore strategies for overcoming or managing antiviral resistance in HCV treatment.

Main Methods:

  • Literature review of recent research on HCV NS5B polymerase inhibitors.
  • Analysis of clinical trial data and preclinical studies on DAAs.
  • Examination of mechanisms of antiviral resistance and proposed countermeasures.

Main Results:

  • Several classes of NS5B inhibitors are in various stages of clinical development.
  • Emergence of drug-resistant HCV variants is a significant challenge impacting treatment durability.
  • Understanding resistance pathways is crucial for developing effective combination therapies.

Conclusions:

  • Direct-acting antivirals targeting NS5B offer a promising new avenue for HCV treatment.
  • Strategies to mitigate antiviral resistance, such as combination therapy and novel drug development, are essential for achieving sustained virologic response.
  • Further research is needed to optimize DAA regimens and overcome resistance.
Keywords:
HCV NS5B polymerase inhibitorsdrug resistancegenetic barrierviral fitness

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...